Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeevan Kumar

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
Bioorganic & Medicinal Chemistry|February 21, 2021
Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetesSuresh Pola, Shailesh R Shah, Harikishore Pingali, et al.
Bioorganic & Medicinal Chemistry Letters|April 12, 2022
Optimisation of momelotinib with improved potency and efficacy as pan-JAK inhibitorJigar Desai, Bhaumin Patel, Archana Gite, et al.
Bioorganic Chemistry|November 20, 2022
Design, synthesis and biological evaluation of novel pyrazolo-pyrimidin-amines as potent and selective BTK inhibitorsDarshan Joshi, Rajesh Bahekar, Shubhangi Soman, et al.
Bioorganic Chemistry|April 26, 2020
Discovery of diaminopyrimidine-carboxamide derivatives as JAK3 inhibitorsRajesh Bahekar, Nandini Panchal, Shubhangi Soman, et al.
European Journal of Medicinal Chemistry|November 6, 2012
Synthesis and structure-activity relationship of potent, selective and orally active anthranilamide-based factor Xa inhibitors: application of weakly basic sulfoximine group as novel S4 binding elementVrajesh Pandya, Mukul Jain, Ganes Chakrabarti, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 13, 2019
Spectrum and Immunophenotypic Profile of Acute Leukemia: A Tertiary Center Flow Cytometry ExperienceNishit Gupta, Ravikiran Pawar, Sambhunath Banerjee, et al.
Cytometry. Part B, Clinical Cytometry|February 5, 2019
FxCycle™ Based Ploidy Correlates with Cytogenetic Ploidy in B-Cell Acute Lymphoblastic Leukemia and Is Able to Detect the Aneuploid Minimal Residual Disease CloneNishit Gupta, Mayur Parihar, Sambhunath Banerjee, et al.
Future Oncology (London, England)|December 20, 2023
Daratumumab in Indian patients with relapsed and refractory multiple myeloma: a prospective, multicenter, phase IV studyLalit Kumar, Sameer Melinkeri, Prasanth Ganesan, et al.
Frontiers in Oncology|February 7, 2022
Relapsed Refractory Hodgkin Lymphoma and Brentuximab Vedotin-Bendamustine Combination Therapy as a Bridge to Transplantation: Real-World Evidence From a Middle-Income Setting and Literature ReviewVivek S Radhakrishnan, Rajat Bajaj, Vasundhara Raina, et al.
Cureus|July 6, 2026
Efficacy and Safety of Bruton Tyrosine Kinase Inhibitors in Waldenström Macroglobulinemia: A Single-Center Retrospective AnalysisMitali Singh, Dibakar Podder, Arjin P Jacoby, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Bioorganic & Medicinal Chemistry|February 21, 2021
Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetesSuresh Pola, Shailesh R Shah, Harikishore Pingali, et al.
Bioorganic & Medicinal Chemistry Letters|April 12, 2022
Optimisation of momelotinib with improved potency and efficacy as pan-JAK inhibitorJigar Desai, Bhaumin Patel, Archana Gite, et al.
Bioorganic Chemistry|November 20, 2022
Design, synthesis and biological evaluation of novel pyrazolo-pyrimidin-amines as potent and selective BTK inhibitorsDarshan Joshi, Rajesh Bahekar, Shubhangi Soman, et al.
Bioorganic Chemistry|April 26, 2020
Discovery of diaminopyrimidine-carboxamide derivatives as JAK3 inhibitorsRajesh Bahekar, Nandini Panchal, Shubhangi Soman, et al.
European Journal of Medicinal Chemistry|November 6, 2012
Synthesis and structure-activity relationship of potent, selective and orally active anthranilamide-based factor Xa inhibitors: application of weakly basic sulfoximine group as novel S4 binding elementVrajesh Pandya, Mukul Jain, Ganes Chakrabarti, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 13, 2019
Spectrum and Immunophenotypic Profile of Acute Leukemia: A Tertiary Center Flow Cytometry ExperienceNishit Gupta, Ravikiran Pawar, Sambhunath Banerjee, et al.
Cytometry. Part B, Clinical Cytometry|February 5, 2019
FxCycle™ Based Ploidy Correlates with Cytogenetic Ploidy in B-Cell Acute Lymphoblastic Leukemia and Is Able to Detect the Aneuploid Minimal Residual Disease CloneNishit Gupta, Mayur Parihar, Sambhunath Banerjee, et al.
Future Oncology (London, England)|December 20, 2023
Daratumumab in Indian patients with relapsed and refractory multiple myeloma: a prospective, multicenter, phase IV studyLalit Kumar, Sameer Melinkeri, Prasanth Ganesan, et al.
Frontiers in Oncology|February 7, 2022
Relapsed Refractory Hodgkin Lymphoma and Brentuximab Vedotin-Bendamustine Combination Therapy as a Bridge to Transplantation: Real-World Evidence From a Middle-Income Setting and Literature ReviewVivek S Radhakrishnan, Rajat Bajaj, Vasundhara Raina, et al.
Cureus|July 6, 2026
Efficacy and Safety of Bruton Tyrosine Kinase Inhibitors in Waldenström Macroglobulinemia: A Single-Center Retrospective AnalysisMitali Singh, Dibakar Podder, Arjin P Jacoby, et al.
Pageof 16